These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33277453)

  • 1. Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection.
    Aghaaliakbari F; Abbasi MA; Ranjbar M; Jamshidi Makiani M; Farrokhpour M; Safarnezhad Tameshkel F; Karbalaie Niya MH; Doltkhah S; Yaghoobzadeh K; Savaj S
    Iran J Kidney Dis; 2020 Dec; 14(6):482-487. PubMed ID: 33277453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.
    Alguwaihes AM; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alzahrani SH; Sabico S; Al-Daghri NM; Jammah AA
    Cardiovasc Diabetol; 2020 Dec; 19(1):205. PubMed ID: 33278893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.
    Palazzuoli A; Mancone M; De Ferrari GM; Forleo G; Secco GG; Ruocco GM; D'Ascenzo F; Monticone S; Paggi A; Vicenzi M; Palazzo AG; Landolina M; Taravelli E; Tavazzi G; Blasi F; Infusino F; Fedele F; De Rosa FG; Emmett M; Schussler JM; Tecson KM; McCullough PA
    J Am Heart Assoc; 2020 Nov; 9(22):e017364. PubMed ID: 33023356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives.
    Khalangot M; Sheichenko N; Gurianov V; Zakharchenko T; Kravchenko V; Tronko M
    Front Endocrinol (Lausanne); 2023; 14():1077959. PubMed ID: 36755914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hypertension with mortality in patients hospitalised with COVID-19.
    Bhatia KS; Sritharan HP; Ciofani J; Chia J; Allahwala UK; Chui K; Nour D; Vasanthakumar S; Khandadai D; Jayadeva P; Bhagwandeen R; Brieger D; Choong C; Delaney A; Dwivedi G; Harris B; Hillis G; Hudson B; Javorski G; Jepson N; Kanagaratnam L; Kotsiou G; Lee A; Lo ST; MacIsaac AI; McQuillan B; Ranasinghe I; Walton A; Weaver J; Wilson W; Yong ASC; Zhu J; Van Gaal W; Kritharides L; Chow CK; Bhindi R
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34876491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of acute kidney injury developing outside the hospital in elderly.
    Turgutalp K; Bardak S; Horoz M; Helvacı I; Demir S; Kiykim AA
    Int Urol Nephrol; 2017 Jan; 49(1):113-121. PubMed ID: 27704319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report.
    Conway J; Gould A; Westley R; Raju SA; Oklopcic A; Broadbent A; Abdelhafiz AH; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Nov; 169():108460. PubMed ID: 32971153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
    Chen C; Wang F; Chen P; Jiang J; Cui G; Zhou N; Moroni F; Moslehi JJ; Ammirati E; Wang DW
    J Am Heart Assoc; 2020 Nov; 9(21):e017736. PubMed ID: 32807002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antihypertensive therapy among patients with COPD.
    Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
    Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry].
    Shestakova MV; Vikulova OK; Isakov MА; Dedov II
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):35-46. PubMed ID: 33351311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
    Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N;
    JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
    Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
    Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
    Shih CJ; Chen HT; Kuo SC; Li SY; Lai PH; Chen SC; Ou SM; Chen YT
    CMAJ; 2016 May; 188(8):E148-E157. PubMed ID: 27001739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.
    Vila-Córcoles A; Ochoa-Gondar O; Satué-Gracia EM; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Basora-Gallisà J
    BMJ Open; 2020 Dec; 10(12):e041577. PubMed ID: 33303459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a nationwide study.
    Shih CJ; Chen HT; Chao PW; Kuo SC; Li SY; Yang CY; Tarng DC; Ou SM; Chen YT
    J Hypertens; 2016 Mar; 34(3):567-74; discussion 575. PubMed ID: 26703918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.